Permanent Supportive Housing Overdose Prevention+ Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based practices to prevent tenant overdose and improve tenant health.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Serve at least 40 tenants in New York and/or New Jersey
Have a significant concern for overdose (as demonstrated by past year tenant overdose)
Be willing to complete all activities required for participation in the trial
Must live in an enrolled Supportive Housing Agency
Disqualifiers
See inclusion criteria.
Trial design
Design model
Crossover
Treatments tested in this trial
TA Intervention
BehavioralTechnical assistance (TA) intervention designed to support PSH agencies in sustainably implementing evidence-based practices to reduce tenant overdose and improve tenant health more broadly.
Treatment groups
2,940 Participants
are divided into 4 treatment groupsGroup A: Wave 1: Control, Intervention, SustainmentExperimental treatment 1 intervention
Group B: Wave 2: Control, Intervention, SustainmentExperimental treatment 1 intervention
Group C: Wave 3: Control, Intervention, SustainmentExperimental treatment 1 intervention
Group D: Wave 4: Control, Intervention, SustainmentExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Composite Score of Agency-Level Fidelity to Overdose Prevention Evidence-Based Practices
Fidelity will be measured as the extent to which an intervention is implemented as intended by researchers; the specific method of measurement will be determined during the trial's preparatory phase, in consultation with multiple stakeholders. The measurement will comprise a composite score of multiple measures.
Time frame
Baseline, Month 12 (End of Wave 1), Month 19 (End of Wave 2), Month 26 (End of Wave 3), Month 33 (End of Wave 4)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
NYU Langone Health
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: